All posts by: Michael Zand

About Michael Zand

Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington

KIRKLAND, Wash., Nov. 9 /PRNewswire-FirstCall/ — CellCyte Genetics Corporation (OTC Bulletin Board: CCYG) announced today that is has received notice of the issuance of a U.S. patent (U.S. Patent No. 7,282,222) for its unique methods and compositions approach to deliver and direct stem cells to target organs in the body. Using this now-patented technology, exclusively … Continue reading

2012-11-25 Business

Nanoparticles help researchers deliver steroids to retina

Research at Wayne State University, Mayo Clinic and Johns Hopkins offers potential treatment for macular degeneration and retinitis pigmentosa DETROIT — Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A collaborative research study among investigators at Wayne State University, the Mayo … Continue reading

2012-11-25 NEWS

Manhattan Beach Project

Will You Be Part of the Last Generation to Die From Aging or… Part of the First to Enjoy Open-Ended Youth? Scientists are uncovering the path to longer and more vibrant lives… for everyone. Age-Reversing breakthroughs occur faster and more often than ever before. Now… YOU can have “first-access” to groundbreaking information, therapies and technologies discovered by … Continue reading

2012-11-25 Anti-aging

Ken Chien: The road ahead for regenerative medicine

Human models of human disease are likely to be the first benefits of stem cells to medicine Kenneth Chien, Massachusetts General Hospital While most therapies aim to stall the advance of debilitating disease, regenerative medicine strives to reverse it. Kenneth Chien of the Harvard Stem Cell Institute and the Cardiovascular Research Center at Massachusetts General Hospital describes … Continue reading

2012-11-25 NEWS